Free Trial
LON:C4XD

C4X Discovery (C4XD) Share Price, News & Analysis

C4X Discovery logo

About C4X Discovery Stock (LON:C4XD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
12
12
52-Week Range
N/A
Volume
3.77 million shs
Average Volume
1.18 million shs
Market Capitalization
£30.27 million
P/E Ratio
300.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive C4XD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter.

C4XD Stock News Headlines

Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

C4XD Stock Analysis - Frequently Asked Questions

C4X Discovery Holdings plc (LON:C4XD) announced its quarterly earnings data on Wednesday, April, 29th. The company reported ($5.02) EPS for the quarter, beating the consensus estimate of ($5.50) by $0.48. C4X Discovery had a trailing twelve-month return on equity of 55.38% and a net margin of 42.81%.

Shares of C4XD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that C4X Discovery investors own include The Berkeley Group (BKG), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC) and Intel (INTC).

Company Calendar

Last Earnings
4/29/2020
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:C4XD
CIK
N/A
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0.04
Trailing P/E Ratio
300.00
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£10.57 million
Net Margins
42.81%
Pretax Margin
N/A
Return on Equity
55.38%
Return on Assets
28.04%

Debt

Debt-to-Equity Ratio
1.05
Current Ratio
15.31
Quick Ratio
9.82

Sales & Book Value

Annual Sales
£24.68 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
4.00
Book Value
GBX 10 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
252,230,000
Free Float
N/A
Market Cap
£30.27 million
Optionable
Not Optionable
Beta
0.23
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:C4XD) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners